NO985572L - Substituerte amidinobenzenderivater og medisinske preparater derav - Google Patents

Substituerte amidinobenzenderivater og medisinske preparater derav

Info

Publication number
NO985572L
NO985572L NO985572A NO985572A NO985572L NO 985572 L NO985572 L NO 985572L NO 985572 A NO985572 A NO 985572A NO 985572 A NO985572 A NO 985572A NO 985572 L NO985572 L NO 985572L
Authority
NO
Norway
Prior art keywords
medical preparations
substituted
derivatives
amidinobenzene derivatives
substituted amidinobenzene
Prior art date
Application number
NO985572A
Other languages
English (en)
Other versions
NO312097B1 (no
NO985572D0 (no
Inventor
Yuzo Matsumoto
Seijiro Akamatsu
Masato Ichihara
Tomihisa Kawasaki
Seiji Kaku
Isao Yanagisawa
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO985572D0 publication Critical patent/NO985572D0/no
Publication of NO985572L publication Critical patent/NO985572L/no
Publication of NO312097B1 publication Critical patent/NO312097B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19985572A 1996-05-30 1998-11-27 Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse NO312097B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13727396 1996-05-30
PCT/JP1997/001804 WO1997045413A1 (fr) 1996-05-30 1997-05-28 Derives amidinobenzene substitue et compositions les comportant

Publications (3)

Publication Number Publication Date
NO985572D0 NO985572D0 (no) 1998-11-27
NO985572L true NO985572L (no) 1999-01-26
NO312097B1 NO312097B1 (no) 2002-03-18

Family

ID=15194827

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985572A NO312097B1 (no) 1996-05-30 1998-11-27 Substituerte amidinobenzenderivater og farmasöytiske preparater som omfatter disse

Country Status (18)

Country Link
US (1) US6057324A (no)
EP (1) EP0905129A4 (no)
KR (1) KR20000016164A (no)
CN (1) CN1221405A (no)
AR (1) AR008374A1 (no)
AU (1) AU720233B2 (no)
BR (1) BR9709277A (no)
CA (1) CA2250038A1 (no)
CZ (1) CZ389698A3 (no)
HU (1) HUP9903539A3 (no)
ID (1) ID16991A (no)
NO (1) NO312097B1 (no)
PL (1) PL330204A1 (no)
RU (1) RU2158263C2 (no)
SK (1) SK162498A3 (no)
TW (1) TW403745B (no)
WO (1) WO1997045413A1 (no)
ZA (1) ZA974422B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7635698B2 (en) * 2004-12-29 2009-12-22 Millennium Pharmaceuticals, Inc. Compounds useful as chemokine receptor antagonists
US7880002B2 (en) * 2004-12-29 2011-02-01 Millennium Pharmaceuticals, Inc. Substituted piperazinyl-pyrrolidine compounds useful as chemokine receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0612313A1 (en) * 1991-11-14 1994-08-31 Glaxo Group Limited Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
WO1996024583A1 (fr) * 1995-02-10 1996-08-15 Yamanouchi Pharmaceutical Co., Ltd. Nouveaux derives de benzamidine et leur composition medicinale
JPH0987280A (ja) * 1995-09-28 1997-03-31 Yamanouchi Pharmaceut Co Ltd オキソピペラジン誘導体又はその塩

Also Published As

Publication number Publication date
AU2975997A (en) 1998-01-05
NO312097B1 (no) 2002-03-18
WO1997045413A1 (fr) 1997-12-04
EP0905129A4 (en) 2000-03-15
BR9709277A (pt) 1999-08-10
RU2158263C2 (ru) 2000-10-27
CZ389698A3 (cs) 1999-02-17
AR008374A1 (es) 2000-01-19
ZA974422B (en) 1997-12-22
US6057324A (en) 2000-05-02
CN1221405A (zh) 1999-06-30
NO985572D0 (no) 1998-11-27
TW403745B (en) 2000-09-01
KR20000016164A (ko) 2000-03-25
SK162498A3 (en) 1999-06-11
PL330204A1 (en) 1999-04-26
CA2250038A1 (en) 1997-12-04
HUP9903539A3 (en) 2002-01-28
AU720233B2 (en) 2000-05-25
ID16991A (id) 1997-11-27
EP0905129A1 (en) 1999-03-31
HUP9903539A2 (hu) 2000-05-28

Similar Documents

Publication Publication Date Title
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
NO953991D0 (no) Ultrasomisk og elektro-kirurgisk håndstykke av piezotype
NO943511L (no) Farmasöytiske preparater og anvendelse derav
NO20014219D0 (no) <Kappa>-agonist-forbindelser og farmasöytiske preparater derav
NO961425D0 (no) 1N-alkyl-N-arylpyrimidinaminer og derivater derav
ID17948A (id) Piridine bersumbu heterosiklik
NO306401B1 (no) Oksazolidindionderivater, farmasöytisk preparat inneholdende slike derivater, og deres anvendelse
IS4481A (is) Díhýdrópyramídín og notkun þeirra
NO983235L (no) Fikstur og protese innbefattende samme
NO307707B1 (no) Spiroazabicykliske forbindelser, farmasøytisk preparat inneholdende slike forbindelser og anvendelse derav
DE69221059T2 (de) Indolderivate und antiulcerose Zubereitungen
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
NO975439D0 (no) Ketonderivater og medisinsk anvendelse derav
KR960700239A (ko) 크로만 유도체 및 그의 제약학적 용도(chroman derivative and medicinal use thereof)
NO961274D0 (no) Azolderivat og farmasöytiske preparat derav
DK0906301T3 (da) Benzofurylderivater og anvendelsen deraf
NO307092B1 (no) Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding
DE69705324T2 (de) N-hydroxyharnstoffderivate und sie enthaltende medizinische zubereitungen
NO20006576D0 (no) Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette
NO992676D0 (no) 1,4-diazabicyklo[2,2,2]okt-2-ylmetylderivater, deres fremstilling og terapeutiske anvendelse
NO973980D0 (no) Imiadazolderivater og medisinsk preparat
DK0826679T3 (da) Naphthylforbindelser og -præparater
NO971505D0 (no) Trofinin og trofininhjelperproteiner
DE69223686T2 (de) LFA-3-Protein und Derivate
NO984921D0 (no) Tienopyridinderivater og deres anvendelse

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002